Private Equity Firm Healthcare

Frist Cressey Ventures

Nashville, Tennessee, United States

Venture capital firm on a mission to transform healthcare and improve lives, partnering with healthcare and health IT companies with capital and strategic support.

Focus Areas
Health IT, Healthcare services, Digital health
Website
fcventures.com

Tracked deals

3

3 tracked deals across 2019-2024.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Growth capital

3 growth capital

Frist Cressey Ventures Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Frist Cressey Ventures. 1 2019 1 2022 1 2024

Supporting Data

Recent Transactions

  • Buyer
    Vitruvian Partners, BIP Ventures, Frist Cressey Ventures
    Target
    ObjectiveHealth

    Vitruvian Partners has made a strategic growth investment in ObjectiveHealth, an integrated specialty clinical research network and health technology company headquartered in Franklin, Tennessee. The capital will support ObjectiveHealth’s expansion of operations, geographic reach and continued development of its AI-driven patient identification and trial management technology; existing investors BIP Ventures and Frist Cressey Ventures will remain partners.

  • Buyer
    Banneker Partners, Frist Cressey Ventures
    Target
    Hint Health

    Hint Health, a San Francisco-based provider of membership management and billing software for direct primary care (DPC) providers, announced a $45 million funding round led by Banneker Partners and Frist Cressey Ventures. The growth capital will be used to expand the HintOS platform, grow the national Hint Connect DPC network, and increase services for virtual-first and near-site/on-site employer-contracted clinics.

  • Buyer
    TT Capital Partners, NovaQuest Capital Management, Frist Cressey Ventures
    Target
    InformedDNA

    InformedDNA, the U.S. leader in genetics services, has entered definitive agreements with TT Capital Partners, NovaQuest Capital Management, and Frist Cressey Ventures to receive a growth capital investment to scale its technology-enabled genetic services and expand its genetic counseling staff. Terms were not disclosed; InformedDNA will remain led by CEO David Nixon and has also secured a flexible credit facility from CIBC.

Related Acquisition Pages

Selling a company? Get in front of buyers like Frist Cressey Ventures

Turn tracked acquisition activity into an outreach-ready buyer list.